[ Price : $8.95]
FDA approves an EUSA Pharma NDA for Erwinaze (asparaginase Erwinia chrysanthemi) to treat certain patients with acute lymphoblasti...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on a special controls guidance for natural rubber latex ...[ Price : $8.95]
CDERs Drug Safety Oversight Board reviews reports of needle detachments occurring with Janssens antipsychotic Risperdal Consta.[ Price : $8.95]
FDA approves Abbotts ESA Chagas [Trypanosoma cruzi (E. coli, recombinant) antigen], the first in vitro enzyme strip assay for use ...[ Price : $8.95]
FDA extends by three months its review of Takeda Pharmaceutical NDAs for the investigational Type 2 diabetes therapy alogliptin, a...[ Price : $8.95]
In an anticipated move, FDA issues a revocation order on a metastatic breast cancer indication for Genentechs Avastin (bevacizumab...[ Price : $8.95]
Washington commentator Robert F. Steeves congratulates commissioner Hamburg and FDA for apparently following his advice in conveni...[ Price : $8.95]
FDA accepts a Chelsea Therapeutics NDA for Northera (droxidopa), an orally active synthetic precursor of norepinephrine for treati...